US Pharma MarketingNimbus Therapeutics’ head of R&D dishes on what’s next in AI-enabled drug discovery, years after Takeda completed its zasocitinib acquisition.
Nimbus used AI to help develop Takeda’s $4B psoriasis bet. Here’s where it’s taking the tech next
Nimbus Therapeutics’ head of R&D dishes on what’s next in AI-enabled drug discovery, years after Takeda completed its zasocitinib acquisition.
Source: PharmaVoice